AEON Biopharma, Inc. (AEON)
0.1618
0.00 (0.00%)
USD |
NYAM |
Nov 06, 10:15
AEON Biopharma Debt to Equity Ratio : -0.1807 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1807 |
| March 31, 2026 | -0.1567 |
| December 31, 2025 | -0.6496 |
| September 30, 2025 | -0.9186 |
| June 30, 2025 | -1.037 |
| March 31, 2025 | -1.289 |
| December 31, 2024 | -0.4535 |
| September 30, 2024 | -0.5142 |
| June 30, 2024 | -0.5256 |
| March 31, 2024 | -0.0267 |
| December 31, 2023 | -0.003 |
| September 30, 2023 | -0.0008 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.1028 |
| March 31, 2023 | 0.011 |
| December 31, 2022 | -0.8812 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0004 |
| December 31, 2020 | 1.804 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0413 |
| Alnylam Pharmaceuticals, Inc. | 0.8316 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.91M |
| Total Liabilities (Quarterly) | 21.27M |
| Shareholders Equity (Quarterly) | -15.36M |
| Current Ratio | 0.5439 |
| Net Debt Paydown Yield | 12.50% |